| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 3,750 | 3,750 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| INVESTMENT - MS 8754 | 4,088 | 16,030 |
| INVESTMENT - MS 4921 | 1,268,526 | 1,935,380 |
| INVESTMENT - UBS 6772 | 420,976 | 1,140,365 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| INVESTMENT IN APPLIED STEMCELL INC | AT COST | 52,500 | 52,500 |
| INVESTMENT IN NEXBIO | AT COST | 571,170 | 571,170 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| INVESTMENT IN SEMANTICMD, INC. | 175,000 | 0 | 0 |
| INVESTMENT IN 7 HILLS PHARMA LLC | 68,000 | 22,771 | 22,771 |
| Description | Amount |
|---|---|
| ADJUSTMENT FOR DIFFERENCE IN COST BASIS | 267,151 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| INVESTMENT IN 7 HILLS PHARMA, LLC | -51,655 | -51,655 |
| Description | Amount |
|---|---|
| MISCELLANEOUS | 137 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT FEES | 17,701 | 17,701 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 328 | 328 | 0 | |
| FEDERAL TAXES | 335 | 0 | 0 |